Add like
Add dislike
Add to saved papers

Comparative toxicity of silver nanoparticles (AgNPs) and silver nanowires (AgNWs) on saltwater microcrustacean, Artemia salina.

This study evaluated the potential toxic effects of silver nanoparticles (AgNPs) and silver nanowires (AgNWs) on saltwater microcrustacean Artemia salina nauplii under ISO TS 20787 guideline. To investigate the acute toxicity of these nanomaterials, the nauplii were exposed to different concentrations of 0 (control), 0.39, 1.56, 6.25, 25 and 100 mg/L AgNPs and concentrations of 0 (control), 0.01, 0.1, 1, 10, 50 and 100 mg/L AgNWs for 72 h. Immobilization rate of A. salina exposed to both AgNPs and AgNWs for 72 h increased significantly in a concentration-dependent manner (P < 0.05). The 72 h EC10 and EC50 were found to be 1.48 ± 0.6 and 10.70 ± 1.3 mg/L for AgNPs, respectively, and 0.03 ± 0.02 and 0.43 ± 0.04 mg/L for AgNWs, respectively. Based on the EC10 and EC50 values, the toxicity of AgNWs was significantly higher than AgNPs (P < 0.05). Oxidative stress resulted from 48 h exposure to both AgNPs and AgNWs in A. salina was assessed by measuring reactive oxygen species (ROS) production and superoxide dismutase (SOD) activity. The results revealed that both AgNPs and AgNWs could induce ROS production. The SOD activity decreased significantly with the increase of exposure concentration (P < 0.05). In conclusion, the present results show that both nanomaterials have toxic effects on A. salina nauplii and thus, more effort should be made to prevent their release into saltwater ecosystems and trophic transfer in the aquatic food chain.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app